Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.74 is 42% below its 2-year average of 9.96, near the low end of its 2-year range (4.88–16.78).
As of the fiscal period ended Tuesday, June 30, 2026. 46.02% below its 12-month average of 10.64.
Reported quarterly current ratio; no daily interpolation. Q4 FY2026 (2026-06-30): 5.74.
CURRENT RATIO
5.74
CURRENT RATIO AVG TTM
10.64
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-46.02%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.54
median of 736 covered companies
CURRENT VS SECTOR MEDIAN
+62.05%
vs the sector median at left
Market Cap
$48.27M
Current Ratio
2.28
TTM Avg
1.96
3Y Avg
1.81
5Y Avg
1.76
Market Cap
$51.13M
Current Ratio
3.74
TTM Avg
0.21
3Y Avg
0.34
5Y Avg
1.39
Market Cap
$51.28M
Current Ratio
5.31
TTM Avg
2.85
3Y Avg
8.26
5Y Avg
15.41
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lite Strategy, Inc. (LITS) | $48.65M | 5.74 | 10.64 | N/A | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.27M | 2.28 | 1.96 | 1.81 | 1.76 |
| Apollomics, Inc. (APLM)vs › | $49.85M | 0.96 | 1.17 | 2.45 | 5.02 |
| Microbot Medical Inc. (MBOT)vs › | $50.20M | 18.56 | 12.85 | 8.01 | 9.80 |
| Celularity Inc. (CELU)vs › | $50.58M | 0.09 | 0.27 | 0.34 | 1.05 |
| INmune Bio, Inc. (INMB)vs › | $50.64M | 4.04 | 3.34 | 3.69 | 7.87 |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.13M | 3.74 | 0.21 | 0.34 | 1.39 |
| Envoy Medical, Inc. (COCH)vs › | $51.34M | 1.73 | 0.89 | 0.86 | 0.91 |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.28M | 5.31 | 2.85 | 8.26 | 15.41 |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | 3.81 | 5.31 | 3.36 | 3.21 |
Current Ratio
5.74
Quick Ratio
5.74
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.74 |
| 2026-03-31 | 11.53 |
| 2025-12-31 | 10.04 |
| 2025-09-30 | 12.39 |
| 2025-06-30 | 13.50 |
| 2025-03-31 | 16.78 |
| 2024-12-31 | 10.66 |
| 2024-09-30 | 9.66 |
| 2024-06-30 | 4.88 |
| 2024-03-31 | 6.17 |
| 2023-12-31 | 8.23 |
